Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00789945 · ClinicalTrials.gov registry record · NA
Timing of Insulin Before Meals Everyday
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT00789945 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 76 participants.
The verdict
NCT00789945, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The inclusion of "Timing of premeal insulin administration (Timing)" in an Intensive Insulin Therapy regimen will reduce A1C by an average of 1% in type 1 diabetic patients who have initial A1C's between 7.0% and 9.0%.
Interventions
- OTHER Control
- OTHER Study Arm B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00789945
The ClinicalTrials.gov registry entry for NCT00789945 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00789945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00789945 about?
NCT00789945 is a clinical study titled "Timing of Insulin Before Meals Everyday". The inclusion of "Timing of premeal insulin administration (Timing)" in an Intensive Insulin Therapy regimen will reduce A1C by an average of 1% in type 1 diabetic patients who have initial A1C's between 7.0% and 9.0%.
What is the current status of trial NCT00789945?
This trial is currently terminated. It is a NA study. The enrollment target is 76 participants. The study started on 2008-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00789945?
The interventions under investigation include: Control (OTHER), Study Arm B (OTHER).
Who is sponsoring clinical trial NCT00789945?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.